COMMUNITY-ACQUIRED PNEUMONIA

โœ“ Medically ReviewedRESPIRATORYID: MDBTH001ICD-11: CA40๐Ÿšจ CRITICAL PROTOCOL
๐Ÿ’ก Core Clinical Guidance

Community-acquired pneumonia (CAP) is an acute infection of the pulmonary parenchyma acquired outside of a hospital or healthcare facility. It is characterised by symptoms of lower respiratory tract infection including cough, fever, sputum production, and pleuritic chest pain, along with the presence of a new infiltrate on chest imaging.

๐Ÿ“–

Definition

CLINICAL DEFINITION & PATHOPHYSIOLOGY

Community-acquired pneumonia (CAP) is an acute infection of the pulmonary parenchyma acquired outside of a hospital or healthcare facility. It is characterised by symptoms of lower respiratory tract infection including cough, fever, sputum production, and pleuritic chest pain, along with the presence of a new infiltrate on chest imaging.

๐Ÿ’Š

Pharmacological Management โ˜…

FIRST-LINE REGIMENS
1 gPOEvery 8 hours5 days

First choice for low-severity CAP (CURB-65 0โ€“1)

ALTERNATIVE & ESCALATION REGIMENS

๐Ÿ’Š Doxycycline

100 mgPOTwice daily5 days

For penicillin-allergic patients or suspected atypical organisms

๐Ÿ’Š Clarithromycin

500 mgPOTwice daily5 days

Alternative macrolide; avoid if QT prolongation risk

ADJUNCTIVE & ADD-ON THERAPIES

๐Ÿ’Š Add clarithromycin 500 mg BD if moderate severity (CURB-65 score 2)

๐Ÿ’Š Consider IV co-amoxiclav + clarithromycin for severe CAP requiring hospitalisation

๐Ÿ’Š Consider IV piperacillin-tazobactam + clarithromycin if aspiration suspected

SPECIAL PATIENT POPULATIONS
LACTATION
  • Amoxicillin is safe during breastfeeding
  • Avoid doxycycline
PREGNANCY
  • Amoxicillin is first-line (Category B)
  • Avoid doxycycline and fluoroquinolones
  • Erythromycin may be used as an alternative (avoid estolate form)
GERIATRICS
  • Higher mortality โ€” lower threshold for hospitalisation
  • Atypical presentation common (confusion, falls, reduced oral intake without classic fever)
  • Adjust renal dosing as needed
PAEDIATRICS
  • Amoxicillin 80โ€“90 mg/kg/day in 2โ€“3 divided doses
  • Add macrolide if atypical pathogen suspected
  • Consider IV ceftriaxone for severe cases
RENAL IMPAIRMENT
  • Reduce amoxicillin dose if eGFR <30 mL/min
  • Avoid nitrofurantoin
  • Monitor aminoglycoside levels if used
IMMUNOCOMPROMISED
  • Broader-spectrum cover required
  • Consider PCP (Pneumocystis) prophylaxis if HIV with low CD4
  • Liaise with infectious disease team early
HEPATIC IMPAIRMENT
  • Use amoxicillin with caution
  • Avoid clarithromycin in severe hepatic impairment
CONTRAINDICATIONS & SAFETY CAUTIONS
  • Penicillin allergy โ€” avoid amoxicillin and co-amoxiclav
  • QT prolongation โ€” avoid macrolides (clarithromycin, azithromycin)
  • Myasthenia gravis โ€” fluoroquinolones and macrolides may exacerbate
  • Tendon disorders โ€” avoid fluoroquinolones
  • Pregnancy โ€” avoid doxycycline and fluoroquinolones
โš–๏ธCLINICAL NOTICE & EDUCATIONAL DISCLAIMER

All content in Medobo is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional and local institutional protocols before administering medication or initiating treatment.